The aim of this study was to assess the recovery rates of diagnostic cardiac procedure volumes in the Oceania Region, midway through the coronavirus disease 2019 (COVID-19) pandemic. A survey was performed comparing procedure volumes between March 2019 (pre-pandemic), April 2020 (during first wave of COVID-19 pandemic), and April 2021 (1 year into the COVID-19 pandemic). A total of 31 health care facilities within Oceania that perform cardiac diagnostic procedures were surveyed, including a mixture of metropolitan and regional, hospital and outpatient, public and private sites, as well as teaching and non-teaching hospitals. A comparison was made with 549 centres in 96 countries in the rest of the world (RoW) outside of Oceania. The total number and median percentage change in procedure volume were measured between the three timepoints, compared by test type and by facility. A total of 11,902 cardiac diagnostic procedures were performed in Oceania in April 2021 as compared with 11,835 pre-pandemic in March 2019 and 5,986 in April 2020; whereas, in the RoW, 499,079 procedures were performed in April 2021 compared with 497,615 pre-pandemic in March 2019 and 179,014 in April 2020. There was no significant difference in the median recovery rates for total procedure volumes between Oceania (−6%) and the RoW (−3%) (p=0.81). While there was no statistically significant difference in percentage recovery been functional ischaemia testing and anatomical coronary testing in Oceania as compared with the RoW, there was, however, a suggestion of poorer recovery in anatomical coronary testing in Oceania as compared with the RoW (CT coronary angiography -16% in Oceania vs −1% in RoW, and invasive coronary angiography −20% in Oceania vs −9% in RoW). There was no statistically significant difference in recovery rates in procedure volume between metropolitan vs regional (p=0.44), public vs private (p=0.92), hospital vs outpatient (p=0.79), or teaching vs non-teaching centres (p=0.73). Total cardiology procedure volumes in Oceania normalised 1 year post-pandemic compared to pre-pandemic levels, with no significant difference compared with the RoW and between the different types of health care facilities.

中文翻译：

---

COVID-19 爆发一年后大洋洲诊断心脏手术量的恢复率：原子能机构关于 COVID-19 的非侵入性心脏病方案调查（INCAPS COVID 2）

本研究的目的是评估 2019 年冠状病毒病 (COVID-19) 大流行期间大洋洲地区诊断心脏手术量的恢复率。进行了一项调查，比较了 2019 年 3 月（大流行前）、2020 年 4 月（第一波 COVID-19 大流行期间）和 2021 年 4 月（COVID-19 大流行一年后）的手术量。对大洋洲境内总共 31 个执行心脏诊断程序的医疗机构进行了调查，其中包括大都市和地区、医院和门诊、公共和私人场所以及教学和非教学医院。与大洋洲以外的世界其他地区 (RoW) 96 个国家的 549 个中心进行了比较。测量三个时间点之间手术量的总数和中位百分比变化，并按测试类型和设施进行比较。 2021 年 4 月，大洋洲共进行了 11,902 例心脏诊断手术，而 2019 年 3 月大流行前为 11,835 例，2020 年 4 月为 5,986 例；而在世界其他地区，2021 年 4 月进行了 499,079 例手术，而 2019 年 3 月大流行前为 497,615 例，2020 年 4 月为 179,014 例。大洋洲 (-6%) 和RoW (−3%) (p=0.81)。虽然与世界其他地区相比，大洋洲的功能性缺血测试和解剖冠状动脉测试的恢复百分比没有统计学上的显着差异，但有迹象表明，与世界其他地区相比，大洋洲的解剖冠状动脉测试的恢复较差（CT冠状动脉）血管造影在大洋洲为-16%，在世界其他地区为-1%，侵入性冠状动脉造影在大洋洲为-20%，在世界其他地区为-9%）。大城市与地区 (p=0.44)、公立与私立 (p=0.92)、医院与门诊 (p=0.79) 或教学与非教学中心 (p= 0.73）。与大流行前的水平相比，大洋洲的心脏病手术总量在大流行后一年恢复正常，与世界其他地区以及不同类型的医疗机构之间没有显着差异。